Violation Tracker Parent Company Summary

Parent Company Name: 
Johnson & Johnson
Ownership Structure: 
publicly traded (ticker symbol JNJ)
Headquartered in: 
New Jersey
Industry: 
pharmaceuticals
Penalty total since 2000: 
$2,503,352,578
Number of records: 
18
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$2,366,000,0003
Foreign Corrupt Practices Act$70,450,0003
False Claims Act$40,300,0004
drug or medical equipment safety violation$26,200,0002
environmental violation$391,3005
workplace safety or health violation$11,2781
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.

Associated Names: 

ACCLARENT; ADVANCED STERILIZATION PROD; ADVANCED STERILIZATION PROD DIVISION OF ETHICON; JANSSEN PHARMACEUTICA; JANSSEN PHARMACEUTICAL SB; JOHNSON AND JOHNSON; JOHNSON AND JOHNSON MEDICAL; LIFESCAN; McNeil-PPC Inc.; MICRUS; ORTHO MCNEIL PHARMACEUTICAL LLC; Scios Inc.; STERILMED

Links: 

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For more on the links between this company's federal political spending and its positions on proposed legislation, see its Maplight page.


Individual Penalty Records:

Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
Johnson & Johnson off-label or unapproved promotion of medical products 2013 FDA $2,200,000,000
Scios Inc. off-label or unapproved promotion of medical products 2011 FDA $85,000,000
Ortho-McNeil Pharmaceutical LLC off-label or unapproved promotion of medical products 2010 FDA $81,000,000
Johnson & Johnson Foreign Corrupt Practices Act 2011 SEC $48,600,000
McNeil-PPC Inc. drug or medical equipment safety violation 2015 FDA $25,000,000
Johnson & Johnson Foreign Corrupt Practices Act 2011 DOJ_CRIMINAL $21,400,000
Acclarent Inc. False Claims Act 2016 DOJ_CIVIL $18,000,000
Lifescan, Inc. False Claims Act 2001 DOJ_CIVIL $15,000,000
Johnson & Johnson Medical, Inc. False Claims Act 2001 DOJ_CIVIL $3,900,000
Ortho McNeil Pharmaceutical False Claims Act 2009 DOJ_CIVIL $3,400,000
Advanced Sterilization Products, a division of Ethicon Inc. drug or medical equipment safety violation 2013 FDA $1,200,000
Micrus Corporation Foreign Corrupt Practices Act 2005 DOJ_CRIMINAL $450,000
Advanced Sterilization Products environmental violation 2014 EPA $136,800
Advanced Sterilization Products, Division of Ethicon environmental violation 2014 EPA $136,800
Janssen Pharmaceutical (SB) environmental violation 2010 EPA $105,000
STERILMED, INC. workplace safety or health violation 2006 OSHA $11,278
Janssen Pharmaceutica Inc. environmental violation 2004 EPA $7,700
Johnson & Johnson environmental violation 2004 EPA $5,000
Download results as CSV or XML